FetalDNA is a non-invasive prenatal screening test (NIPT) based on the analysis of free fetal DNA circulating on maternal blood, in order to detect the most common fetal aneuploidies in pregnancy such as those related to chromosome 21 (Down syndrome), chromosome 18 (Edwards syndrome), chromosome 13 (Patau syndrome) and the sex chromosomes X and Y (Turner syndrome, Klinefelter).

The FetalDNA Fetal DNA Test provides 8 levels of fetal DNA investigation, with an increasing degree of depth.

From the first – FetalDNA Base – which investigates the most frequent chromosomal abnormalities such as Down Syndrome, Edwards Syndrome and Patau Syndrome, up to the most advanced – FetalDNA Total Screen – which allows for the most complete genetic screening in pregnancy, in addition to information about the entire chromosomal set of the fetus and structural alterations associated with various pathological conditions.

In particular, FetalDNA Base is also aimed at those who perform nuchal translucency in the screening of the first trimester of pregnancy, definitely overcoming the important limits of combined tests (ultrasound and biochemical). This test has a very low cost and provides an extremely rapid response.